We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
+0.11%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$709M
AUM Growth
+$195M
Cap. Flow
-$68.5M
Cap. Flow %
-9.65%
Top 10 Hldgs %
69.09%
Holding
206
New
48
Increased
50
Reduced
50
Closed
43

Top Buys

Rank Stock Value
1
ATER icon
Aterian
ATER
+$8.44M
2
COCP icon
Cocrystal Pharma
COCP
+$7.74M
3
RCON icon
Recon Technology
RCON
+$7.52M
4
LNAI
Lunai Bioworks
LNAI
+$5.46M
5
KRBP
Kiromic BioPharma, Inc. Common Stock
KRBP
+$4.18M

Top Sells

Rank Stock Value
1
VANI icon
Vivani Medical
VANI
+$4.81M
2
PENN icon
PENN Entertainment
PENN
+$4.24M
3
VTSI icon
VirTra
VTSI
+$3.45M
4
ASXC
Asensus Surgical, Inc.
ASXC
+$3.42M
5
RVPH
REVIVA PHARMA HLDGS INC
RVPH
+$2.4M

Sector Composition

Rank Sector Weight
1 Healthcare 10.24%
2 Consumer Discretionary 1.47%
3 Technology 1.37%
4 Financials 1.09%
5 Consumer Staples 0.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMPG icon
76
AmpliTech
AMPG
$124M
$1.06M 0.15%
+229,102
New +$1.32M
BCTX
77
Briacell Therapeutics
BCTX
$30.2M
$1.04M 0.15%
1,307
+239
+22% +$149K
DXR icon
78
Daxor
DXR
$62.2M
$1.03M 0.15%
97,487
-21,249
-18% -$225K
LEXXW
79
DELISTED
Lexaria Bioscience Warrant
LEXXW
$1.01M 0.14%
401,246
+110,246
+38% +$287K
PPBT
80
PUT
Purple Biotech
PPBT
$1.28M
$1.01M 0.14%
10
– –
PRFX icon
81
PRF Technologies Ltd
PRFX
$3.25M
$980K 0.14%
290
+15
+5% +$56K
MRTX
82
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$969K 0.14%
6,000
-2,500
-29% -$401K
BPTS
83
DELISTED
Biophytis SA American Depositary Share (0.01 Euro)
BPTS
$964K 0.14%
228
-3
-1% -$14.5K
ATOS icon
84
CALL
Atossa Therapeutics
ATOS
$24.1M
$959K 0.14%
+101
New +$5.35K
SBEV.WS
85
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$947K 0.13%
+860,609
New +$760K
BCLI
86
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$923K 0.13%
16,190
+7,083
+78% +$378K
TRIL
87
PUT
DELISTED
Trillium Therapeutics Inc.
TRIL
$914K 0.13%
942
+360
+62% +$3.39K
MARA icon
88
Marathon Digital Holdings
MARA
$4.34B
$866K 0.12%
+27,590
New +$875K
VANI icon
89
Vivani Medical
VANI
$113M
$864K 0.12%
58,300
-249,098
-81% -$4.81M
CBAT icon
90
CBAK Energy Technology Ltd
CBAT
$43.6M
$825K 0.12%
+175,097
New +$782K
TXMD icon
91
TherapeuticsMD
TXMD
$23.8M
$744K 0.1%
12,500
-3,500
-22% -$212K
CFRX
92
DELISTED
ContraFect Corporation
CFRX
$731K 0.1%
2,077
– –
SHIP icon
93
Seanergy Maritime Holdings
SHIP
$348M
$728K 0.1%
65,000
-134,478
-67% -$1.42M
INFI
94
CALL
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$723K 0.1%
2,418
+1,739
+256% +$5.5K
BTCT icon
95
BTC Digital
BTCT
$8.46M
$712K 0.1%
+1,223
New +$1.05M
VRPX
96
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$704K 0.1%
619
-181
-23% -$194K
LFWD icon
97
PUT
ReWalk Robotics
LFWD
$19.6M
$677K 0.1%
48
+7
+17% +$1.09K
ATHX
98
CALL
DELISTED
Athersys, Inc. Common Stock
ATHX
$622K 0.09%
+173
New +$7.12K
AUPH icon
99
CALL
Aurinia Pharmaceuticals
AUPH
$1.92B
$608K 0.09%
469
– –
AGTC
100
PUT
DELISTED
Applied Genetic Technologies Corporation
AGTC
$604K 0.09%
1,545
-2,230
-59% -$9.24K
2 3
4
5 6

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q2 2021 Portfolio in Review

As of Q2 2021, Sabby Management held 206 positions worth $709M, up 38% from $514M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Sabby Management withdrew a net $68.5M in Q2 2021, closing 43 positions and reducing 50 holdings. Its most notable exit was PENN Entertainment, an estimated $4.24M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Sabby Management opened a new position in Aterian worth $6.33M.

  • Sabby Management's largest Q2 2021 buy was Aterian: 36,083 shares worth $6.33M.
  • Sabby Management added most to Vincerx Pharma, Inc. Common Stock in Q2 2021, an estimated $2.87M increase.
  • Sabby Management's biggest Q2 2021 reduction was Vivani Medical, cutting an estimated $4.81M.
  • Sabby Management fully exited PENN Entertainment in Q2 2021, selling an estimated $4.24M.
  • Sabby Management's ten largest holdings make up 69% of its $709M portfolio in Q2 2021.
  • Sabby Management opened 48 new positions and closed 43 in Q2 2021.
  • Sabby Management's portfolio value rose 38% quarter-over-quarter to $709M.

Based on Sabby Management's 13F filing for Q2 2021, filed 16 Aug 2021.